An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

ABILIFY MYCITE KIT®

Drug Information Related Patent
Hold Company
OTSUKA
Learn More
Dosage and Administration
TABLET;ORAL
Specification
2MG; 5MG; 10MG; 15MG; 20MG; 30MG
Indication
ABILIFY MYCITE KIT® is used in the treatment of schizophrenia in adults, bipolar I disorder, and major depressive disorder in adults.
Use
Instructions for Use
API
ARIPIPRAZOLE
API Structure
We Supply
ARIPIPRAZOLE
Note:

In-house Standard/EP/USP
Facility GMP
USMF/CDE/CEP

null
Note:

null

null
Note:

null

Drug Patent
Patent NoExpiration Date
104411942029/7/26
105175072032/6/13
112293782031/7/11
114644232030/9/15
114769522026/4/28
79780642026/9/14
80176152024/6/16
81140212030/6/21
82589622030/11/25
85454022030/4/27
85472482030/12/18
86748252029/4/9
87181932029/12/5
87593502027/3/2
88477662030/3/29
89450052029/8/19
89562882029/7/6
89614122030/11/17
90607082029/3/5
91195542028/12/16
91259392026/7/28
91495772029/12/15
92580352029/3/5
92689092033/10/15
93204552031/12/15
93871822023/12/25
94333712029/9/15
94445032027/11/19
99419312030/11/4
API Patent
Patent NoExpiration Date
80176152024/6/16

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top